GAG BioScience GmbH.
Completion of the human genome project led to an explosion in available genomic information. Single nucleotide polymorphisms (SNPs) have emerged as a versatile and powerful tool for genotyping almost all variant species. The unique technological platform developed by GAG BioScience is exclusively based on SNP detection and allows genotyping of up to 60,000 samples per day. An analysis robot, a mass spectrometer and a database form a practically self-controlled analysis and documentation system that achieves high-throughput rates of samples with absolute precision. By using a Laboratory Information and Management System, up to 150 million genotypes can be simultaneously retrieved and stored. In cooperation with a partner, GAG BioScience develops new and powerful tools for further data analysis.
Business Development, GAG BioScience GmbH, Hochschulring 40, D-28359 Bremen, Germany. melmer@gag-bioscience.de
Georg
G
Melmer
D000818:Animals; D002417:Cattle; D005838:Genotype; D006801:Humans; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011328:Prions / Q000009:adverse effects / Q000235:genetics / Q000302:isolation & purification; D012608:Scrapie / Q000235:genetics / Q000378:metabolism; D013678:Technology, Pharmaceutical / Q000295:instrumentation / Q000379:methods* / Q000639:trends
D011328:Prions